Twist Bioscience (TWST) Current Leases (2019 - 2026)

Twist Bioscience (TWST) has reported Current Leases for 8 consecutive years, with $8.6 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Current Leases fell 44.33% year-over-year to $8.6 million in Q2 2026; TTM through Jun 2026 was $8.6 million, a 44.33% decrease from a year earlier, with the FY2025 full-year figure at $13.8 million, down 6.64% from the prior year.
• Current Leases was $8.6 million for Q2 2026 at Twist Bioscience, down from $10.4 million in the prior quarter.
• Over five years, Current Leases peaked at $15.5 million in Q2 2025 and troughed at $8.6 million in Q2 2026.
• A 5-year average of $13.7 million and a median of $14.3 million in 2022 frame the typical range for Current Leases.
• Across the five-year window, Current Leases soared 117.47% in 2022 and sank 44.33% in 2026, its largest moves.
• Over 5 years, Current Leases stood at $14.2 million in 2022, then climbed by 4.08% to $14.8 million in 2023, then gained by 1.5% to $15.0 million in 2024, then decreased by 18.55% to $12.2 million in 2025, then decreased by 29.5% to $8.6 million in 2026.
• The last three Current Leases figures came in at $8.6 million (Q2 2026), $10.4 million (Q1 2026), and $12.2 million (Q4 2025), per Business Quant data.